Clover Health Investments Stock - analyst views and Thursday technicals
18.06.2026 - 19:51:45 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 17:50 UTC. Details in the imprint.
Clover Health Investments (US18914F1030) remains a speculative healthcare stock on Thursday, with sentiment and retail activity shaping trading interest rather than fresh company disclosures. Public data from trading and sentiment platforms highlights modest recent attention and a mixed tone among investors.
All news and key data on Clover Health Investments stock
Background reports, filings and market data on Clover Health Investments stock are collected in the ad-hoc-news topic hub and on the company’s own Investor Relations page.
What recent signals show
There is no new dated earnings release, strategic update, SEC 8-K, or major analyst rating change for Clover Health Investments on 06/18/2026 based on checks of the company’s Investor Relations pages and major newswires. The quiet news backdrop leaves traders leaning on technicals, options flows and sentiment screens.
Sentiment aggregation platform Adanos reports a roughly 52% cross-source average bullish reading for Clover Health Investments across Reddit, X and news over the latest seven days, classifying the stock as a “hold” signal in its framework. Discussions, however, diverge notably by platform, underlining how polarized the retail view remains.
Analyst and consensus snapshot
Analyst coverage on Clover Health Investments has thinned compared with the height of the 2021 SPAC boom, and several large houses have not refreshed formal views in recent months. Available consensus data from broker and aggregator pages therefore captures a limited analyst base and should be interpreted cautiously.
StockTItan’s compilation of SEC filings shows that the company continues to file regular 10-Q, 10-K and 8-K documents detailing enrollment trends, operating metrics and strategy for its Medicare Advantage and technology businesses. These filings, rather than frequent rating changes, are currently the primary regular information source.
How the shares trade technically
On Thursday, recent quote data from trading platforms shows Clover Health Investments shares changing hands around the mid-single-digit dollar range, with one snapshot indicating a last price near $4.97 and an intraday move of about 3.4%. This represents a level below prior 2024 peaks, consistent with a volatile small-cap trading pattern.
Liquidity remains supported by active retail participation on platforms such as Stocktwits, where Clover Health Investments stays among the more closely watched healthcare tickers. For technically oriented traders, this combination of relatively low absolute price and visible message-board activity often translates into heightened intraday swings.
The product behind the stock
Clover Health Investments focuses on Medicare Advantage health plans in the United States and on its Clover Assistant platform, a data-driven software tool designed to support physicians in managing patient care. Revenue is primarily generated from insurance premiums and related healthcare services.
Where the stock trades today
The shares of Clover Health Investments (US18914F1030) trade on Nasdaq at about $4.97 as of 06/18/2026, 17:40 UTC, according to recent quote indications.
Clover Health Investments at a glance
- Company: Clover Health Investments Corp.
- ISIN: US18914F1030
- WKN: A2QQ3K
- Ticker: CLOV
- Venue: Nasdaq
- Price (as of 06/18/2026, 17:40 UTC): 4.97 USD
- Market cap: not reliably verifiable on 06/18/2026
- Sector / Industry: Health Care / Managed Care & Health Technology
- Index membership: not a member of major headline indices such as the S&P 500 or Nasdaq-100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
